Patterns of distant metastasis and survival outcomes in de novo metastatic breast cancer according to age groups

被引:0
作者
Liu, Ke [1 ]
Huang, An-Le [2 ]
Chen, Xue-Qin [1 ]
Wu, San-Gang [3 ]
机构
[1] Xiamen Univ, Sch Med, Xiamen Key Lab Clin Efficacy & Evidence Studies Tr, Affiliated Hosp 1, Xiamen, Peoples R China
[2] Xiamen Univ, Affiliated Hosp 1, Sch Med, Dept Endocrinol & Diabet, Xiamen, Peoples R China
[3] Xiamen Univ, Xiamen Key Lab Radiat Oncol, Xiamen Canc Ctr, Sch Med,Dept Radiat Oncol,Affiliated Hosp 1, Xiamen, Peoples R China
来源
FRONTIERS IN ENDOCRINOLOGY | 2024年 / 15卷
关键词
breast cancer; age; prognosis; metastatic patterns; SEER; PROGNOSTIC-FACTOR; YOUNG AGE; STATISTICS; WOMEN; IRRADIATION; MORTALITY; TAMOXIFEN; THERAPY; OLDER;
D O I
10.3389/fendo.2024.1385756
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Is de novo metastatic breast cancer (dnMBC) the same disease in the elderly as in younger breast cancer remains unclear. This study aimed to determine the metastatic patterns and survival outcomes in dnMBC according to age groups. Methods We included patients from the Surveillance Epidemiology and End Results program. Chi-square test, multivariate logistic regression analyses, and multivariate Cox regression models were used for statistical analyses. Results A total of 17719 patients were included. There were 3.6% (n=638), 18.6% (n=3290), 38.0% (n=6725), and 39.9% (n=7066) of patients aged <35, 35-49, 50-64, and >= 65 years, respectively. Older patients had a significantly higher risk of lung metastasis and a significantly lower risk of liver metastasis. There were 19.1%, 25.6%, 30.9%, and 35.7% of patients with lung metastasis in those aged <35, 35-49, 50-64, and >= 65 years, respectively. Moreover, the proportion of liver metastasis was 37.6%, 29.5%, 26.3%, and 19.2%, respectively. Age was the independent prognostic factor associated with breast cancer-specific survival (BCSS) and overall survival (OS). Those aged 50-64 years had significantly inferior BCSS (P<0.001) and OS (P<0.001) than those aged <35 years. Patients aged >= 65 years also had significantly lower BCSS (P<0.001) and OS (P<0.001) than those aged <35 years. However, similar outcomes were found between those aged 35-49 and <35 years. Conclusion Our study suggests that different age groups may affect the metastatic patterns among patients with dnMBC and the survival of younger patients is more favorable than those of older patients.
引用
收藏
页数:14
相关论文
共 53 条
  • [1] Poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: Nationwide survival data in Korea - A report from the Korean Breast Cancer Society
    Ahn, Sei Hyun
    Son, Byung Ho
    Kim, Seok Won
    Kim, Seung Il
    Jeong, Joon
    Ko, Seung-Sang
    Han, Wonshik
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (17) : 2360 - 2368
  • [2] Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice
    Albrengues, Jean
    Shields, Mario A.
    Ng, David
    Park, Chun Gwon
    Ambrico, Alexandra
    Poindexter, Morgan E.
    Upadhyay, Priya
    Uyeminami, Dale L.
    Pommier, Arnaud
    Kuttner, Victoria
    Bruzas, Emilis
    Maiorino, Laura
    Bautista, Carmelita
    Carmona, Ellese M.
    Gimotty, Phyllis A.
    Fearon, Douglas T.
    Chang, Kenneth
    Lyons, Scott K.
    Pinkerton, Kent E.
    Trotman, Lloyd C.
    Goldberg, Michael S.
    Yeh, Johannes T. -H.
    Egeblad, Mikala
    [J]. SCIENCE, 2018, 361 (6409) : 1353 - +
  • [3] Genomic aberrations in young and elderly breast cancer patients
    Azim, Hatem A., Jr.
    Nguyen, Bastien
    Brohee, Sylvain
    Zoppoli, Gabriele
    Sotiriou, Christos
    [J]. BMC MEDICINE, 2015, 13
  • [4] Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial
    Badwe, Rajendra
    Hawaldar, Rohini
    Nair, Nita
    Kaushik, Rucha
    Parmar, Vani
    Siddique, Shabina
    Budrukkar, Ashwini
    Mittra, Indraneel
    Gupta, Sudeep
    [J]. LANCET ONCOLOGY, 2015, 16 (13) : 1380 - 1388
  • [5] Effect of screening and adjuvant therapy on mortality from breast cancer
    Berry, DA
    Cronin, KA
    Plevritis, SK
    Fryback, DG
    Clarke, L
    Zelen, M
    Mandelblatt, JS
    Yakovlev, AY
    Habbema, JDF
    Feuer, EJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (17) : 1784 - 1792
  • [6] Sexual quality of life evaluation after treatment among women with breast cancer under 35years old
    Blouet, Anaise
    Zinger, Marie
    Capitain, Olivier
    Landry, Sebastien
    Bourgeois, Hugues
    Seegers, Valerie Thepot
    Pointreau, Yoann
    [J]. SUPPORTIVE CARE IN CANCER, 2019, 27 (03) : 879 - 885
  • [7] Age at diagnosis in relation to survival following breast cancer: a cohort study
    Brandt, Jasmine
    Garne, Jens Peter
    Tengrup, Ingrid
    Manjer, Jonas
    [J]. WORLD JOURNAL OF SURGICAL ONCOLOGY, 2015, 13
  • [8] Comparison of patterns and prognosis among distant metastatic breast cancer patients by age groups: a SEER population-based analysis
    Chen, Meng-Ting
    Sun, He-Fen
    Zhao, Yang
    Fu, Wen-Yan
    Yang, Li-Peng
    Gao, Shui-Ping
    Li, Liang-Dong
    Jiang, Hong-Lin
    Jin, Wei
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [9] Is Chronic Obstructive Pulmonary Disease a Disease of Aging?
    Cosio, Manuel G.
    Cazzuffi, Riccardo
    Saetta, Marina
    [J]. RESPIRATION, 2014, 87 (06) : 508 - 512
  • [10] A pH-Responsive Host-guest Nanosystem Loading Succinobucol Suppresses Lung Metastasis of Breast Cancer
    Dan, Zhaoling
    Cao, Haiqiang
    He, Xinyu
    Zhang, Zhiwen
    Zou, Lili
    Zeng, Lijuan
    Xu, Yan
    Yin, Qi
    Xu, Minghua
    Zhong, Dafang
    Yu, Haijun
    Shen, Qi
    Zhang, Pengcheng
    Li, Yaping
    [J]. THERANOSTICS, 2016, 6 (03): : 435 - 445